Bayer , the German drugmaker that bought U.S. seed company Monsanto, on Thursday announced the sale of a number of businesses, job cuts affecting 10 percent of its staff and 3.3 billion euros ($3.8 billion) in impairments.
Source:: Reuters – Business News
